Deletion of Complement Factor H–Related Genes CFHR1 and CFHR3 Is Associated with Atypical Hemolytic Uremic Syndrome
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Atypical hemolytic uremic syndrome (aHUS) is associated with defective complement regulation. Disease-associated mutations have been described in the genes encoding the complement regulators complement factor H, membrane cofactor protein, factor B, and factor I. In this study, we show in two independent cohorts of aHUS patients that deletion of two closely related genes, complement factor H-related 1 (CFHR1) and complement factor H-related 3 (CFHR3), increases the risk of aHUS. Amplification analysis and sequencing of genomic DNA of three affected individuals revealed a chromosomal deletion of approximately 84 kb in the RCA gene cluster, resulting in loss of the genes coding for CFHR1 and CFHR3, but leaving the genomic structure of factor H intact. The CFHR1 and CFHR3 genes are flanked by long homologous repeats with long interspersed nuclear elements (retrotransposons) and we suggest that nonallelic homologous recombination between these repeats results in the loss of the two genes. Impaired protection of erythrocytes from complement activation is observed in the serum of aHUS patients deficient in CFHR1 and CFHR3, thus suggesting a regulatory role for CFHR1 and CFHR3 in complement activation. The identification of CFHR1/CFHR3 deficiency in aHUS patients may lead to the design of new diagnostic approaches, such as enhanced testing for these genes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schouten, J. P. (2002) · Nucleic Acids Research · doi:10.1093/nar/gnf056 · Cited by 2,699
Genomic Disorders: Molecular Mechanisms for Rearrangements and Conveyed Phenotypes
Lupski, J. R., & Stankiewicz, P. (2005) · PLoS Genetics · doi:10.1371/journal.pgen.0010049 · Cited by 582
Anti–Factor H Autoantibodies Associated with Atypical Hemolytic Uremic Syndrome
Dragon-Durey, M.-A. G. A., Loirat, C., Cloarec, S., Macher, M.-A., Blouin, J., Nivet, H., Weiss, L., Fridman, W. H., & Frémeaux-Bacchi, V. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004050380 · Cited by 502
Hughes, A. E., Orr, N., Esfandiary, H., Diaz-Torres, M., Goodship, T., & Chakravarthy, U. (2006) · Nature Genetics · doi:10.1038/ng1890 · Cited by 467
Self-citationde Jorge, E. G., Harris, C. L., Esparza-Gordillo, J., Carreras, L., Arranz, E. A., Garrido, C. A., López-Trascasa, M., Sánchez-Corral, P., Morgan, B. P., & de Córdoba, S. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603420103 · Cited by 447
Manuelian, T., Hellwage, J., Meri, S., Caprioli, J., Noris, M., Heinen, S., Jozsi, M., Neumann, H. P. H., Remuzzi, G., & Zipfel, P. F. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16651 · Cited by 350
Self-citationCaprioli, J., Castelletti, F., Bucchioni, S., Bettinaglio, P., Bresin, E., Pianetti, G., Gamba, S., Brioschi, S., Daina, E., Remuzzi, G., et al. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg363 · Cited by 306
Zipfel, P. F., Jokiranta, T. S., Hellwage, J., Koistinen, V., & Meri, S. (1999) · Immunopharmacology · doi:10.1016/s0162-3109(99)00015-6 · Cited by 205
Self-citationAtypical Haemolytic Uraemic Syndrome Associated with a Hybrid Complement Gene
Venables, J. P., Strain, L., Routledge, D., Bourn, D., Powell, H. M., Warwicker, P., Diaz-Torres, M. L., Sampson, A., Mead, P., Webb, M., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030431 · Cited by 195
Self-citationComplement factor H and related proteins: an expanding family of complement-regulatory proteins?
Zipfel, P. F., & Skerka, C. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90155-4 · Cited by 159
Self-citation
Cited by
Atypical Hemolytic–Uremic Syndrome
Noris, M., & Remuzzi, G. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0902814 · Cited by 1,338
Complement regulators and inhibitory proteins
Zipfel, P. F., & Skerka, C. (2009) · Nature Reviews Immunology · doi:10.1038/nri2620 · Cited by 1,264
Self-citationAnderson, D. H., Radeke, M. J., Gallo, N. B., Chapin, E. A., Johnson, P. T., Curletti, C. R., Hancox, L. S., Hu, J., Ebright, J. N., Malek, G., et al. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2009.11.003 · Cited by 727
“The entire spectrum of disease phenotypes caused by variants in the CFH gene has been addressed in recent reviews (Boon et al., 2009; de Cordoba and de Jorge, 2008; Jozsi and Zipfel, 2008; Zipfel et al., 2007).”
Atypical hemolytic uremic syndrome
Loirat, C., & Frémeaux-Bacchi, V. (2011) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-6-60 · Cited by 669
Genome-wide association study identifies susceptibility loci for IgA nephropathy
Gharavi, A. G., Kiryluk, K., Choi, M., Li, Y., Hou, P., Xie, J., Sanna-Cherchi, S., Men, C. J., Julian, B. A., Wyatt, R. J., et al. (2011) · Nature Genetics · doi:10.1038/ng.787 · Cited by 624
Geha, R. S., Notarangelo, L. D., Casanova, J.-L., Chapel, H., Conley, M. E., Fischer, A., Hammarström, L., Nonoyama, S., Ochs, H. D., Puck, J. M., et al. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.08.053 · Cited by 557
Thrombomodulin Mutations in Atypical Hemolytic–Uremic Syndrome
Delvaeye, M., Noris, M., De Vriese, A., Esmon, C. T., Esmon, N. L., Ferrell, G., Del-Favero, J., Plaisance, S., Claes, B., Lambrechts, D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810739 · Cited by 554
Moore, I., Strain, L., Pappworth, I., Kavanagh, D., Barlow, P. N., Herbert, A. P., Schmidt, C. Q., Staniforth, S. J., Holmes, L. V., Ward, R., et al. (2010) · Blood · doi:10.1182/blood-2009-05-221549 · Cited by 357
Self-citationFactor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency
Józsi, M., Licht, C., Strobel, S., Zipfel, S. L. H., Richter, H., Heinen, S., Zipfel, P. F., & Skerka, C. (2008) · Blood · doi:10.1182/blood-2007-09-109876 · Cited by 354
Self-citationBresin, E., Rurali, E., Caprioli, J., Sanchez-Corral, P., Fremeaux-Bacchi, V., Rodriguez de Cordoba, S., Pinto, S., Goodship, T. H. J., Alberti, M., Ribes, D., et al. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012090884 · Cited by 352
Self-citationAtypical Hemolytic Uremic Syndrome
Kavanagh, D., Goodship, T. H., & Richards, A. (2013) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2013.08.003 · Cited by 348
Self-citationEculizumab for Atypical Hemolytic–Uremic Syndrome
Nürnberger, J., Philipp, T., Witzke, O., Saez, A. O., Vester, U., Baba, H. A., Kribben, A., Zimmerhackl, L. B., Janecke, A. R., Nagel, M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmc0808527 · Cited by 346
Maga, T. K., Nishimura, C. J., Weaver, A. E., Frees, K. L., & Smith, R. J. H. (2010) · Human Mutation · doi:10.1002/humu.21256 · Cited by 308
New developments in the genetics, pathogenesis, and therapy of IgA nephropathy
Magistroni, R., D’Agati, V. D., Appel, G. B., & Kiryluk, K. (2015) · Kidney International · doi:10.1038/ki.2015.252 · Cited by 302
Atypical aHUS: State of the art
Nester, C. M., Barbour, T., de Cordoba, S. R., Dragon-Durey, M. A., Fremeaux-Bacchi, V., Goodship, T. H. J., Kavanagh, D., Noris, M., Pickering, M., Sanchez-Corral, P., et al. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.03.246 · Cited by 299
Self-citationthe International Meningococcal Genetics Consortium (2010) · Nature Genetics · doi:10.1038/ng.640 · Cited by 288
De Córdoba, S. R., & De Jorge, E. G. (2007) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2007.03552.x · Cited by 287
Taylor, C. M., Machin, S., Wigmore, S. J., Goodship, T. H. J., & on behalf of a working party from the Renal Association, T. B. C. F. S. I. H. A. T. B. T. S. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07916.x · Cited by 277
Self-citationHeinen, S., Hartmann, A., Lauer, N., Wiehl, U., Dahse, H.-M., Schirmer, S., Gropp, K., Enghardt, T., Wallich, R., Hälbich, S., et al. (2009) · Blood · doi:10.1182/blood-2009-02-205641 · Cited by 272
Self-citationComplement factor H related proteins (CFHRs)
Skerka, C., Chen, Q., Fremeaux-Bacchi, V., & Roumenina, L. T. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2013.06.001 · Cited by 264
Self-citationFactor H family proteins and human diseases
Józsi, M., & Zipfel, P. F. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.04.008 · Cited by 254
Self-citationStevenson, B., Choy, H. A., Pinne, M., Rotondi, M. L., Miller, M. C., DeMoll, E., Kraiczy, P., Cooley, A. E., Creamer, T. P., Suchard, M. A., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001188 · Cited by 248
“The functions of FHR-1 and other factor H-related proteins are poorly understood, but appear to include control of complement activation, cellular adherence and other functions [13,41–45].”
BackgroundFritsche, L. G., Lauer, N., Hartmann, A., Stippa, S., Keilhauer, C. N., Oppermann, M., Pandey, M. K., Köhl, J., Zipfel, P. F., Weber, B. H. F., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq399 · Cited by 203
“Interestingly, the ΔCFHR3/CFHR1 also represents a risk factor for an autoimmune form of the severe kidney disease atypical hemolytic uremic syndrome, called DEAP-HUS (13,14).”
BackgroundInfluentialSelf-citationComplement Mutation-Associated De Novo Thrombotic Microangiopathy Following Kidney Transplantation
Le Quintrec, M., Lionet, A., Kamar, N., Karras, A., Barbier, S., Buchler, M., Fakhouri, F., Provost, F., Fridman, W. H., Thervet, E., et al. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02297.x · Cited by 203
“In addition, a common CFH haplotype with a deletion incorporating the genes encoding CFH-related proteins 1 and 3 (CFHR1 and CFHR3) has been shown to be associated with aHUS (34).”
BackgroundGenomic copy number variation, human health, and disease
Wain, L. V., Armour, J. A., & Tobin, M. D. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60249-x · Cited by 196
Age-related macular degeneration and the complement system
Khandhadia, S., Cipriani, V., Yates, J. R. W., & Lotery, A. J. (2012) · Immunobiology · doi:10.1016/j.imbio.2011.07.019 · Cited by 167
Mele, C., Remuzzi, G., & Noris, M. (2014) · Seminars in Immunopathology · doi:10.1007/s00281-014-0416-x · Cited by 167
“Ninety percent of patients with anti CFH-antibodies have a complete deficiency of CFHR1 and CFHR3 associated with a homozygous deletion of CFHR1 and CFHR3 [86, 106, 107], a polymorphism also observed at a frequency of 4 % in healthy Caucasians that do not develop anti-CFH antibodies.”
BackgroundShaw, P. X., Zhang, L., Zhang, M., Du, H., Zhao, L., Lee, C., Grob, S., Lim, S. L., Hughes, G., Lee, J., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121309109 · Cited by 148
“CFH inhibitory activity in plasma stratified by CFHY402H genotype was assessed by a modified sheep erythrocytes-based hemolytic assay as described previously (47).”
MethodRegulation of regulators: Role of the complement factor H-related proteins
Cserhalmi, M., Papp, A., Brandus, B., Uzonyi, B., & Józsi, M. (2019) · Seminars in Immunology · doi:10.1016/j.smim.2019.101341 · Cited by 131
Self-citationSelf‐nonself discrimination by the complement system
Meri, S. (2016) · FEBS Letters · doi:10.1002/1873-3468.12284 · Cited by 87
Montes, T., Goicoechea de Jorge, E., Ramos, R., Gomà, M., Pujol, O., Sánchez-Corral, P., & Rodríguez de Córdoba, S. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.01.027 · Cited by 47
Metadata
- Authors
- Zipfel, P. F., Edey, M., Heinen, S., Józsi, M., Richter, H., Misselwitz, J., Hoppe, B., Routledge, D., Strain, L., Hughes, A. E., Goodship, J. A., Licht, C., Goodship, T. H. J., & Skerka, C.
- Venue
- PLoS Genetics
- Publisher
- Public Library of Science (PLoS)
- Published
- 2007-03-16
- Volume
- 3
- Issue
- 3
- Pages
- e41
- ISSN
- 1553-7390 (ISSN-L)
- 1553-7404
- OpenAlex
- W2067053006
- Cited by
- 325
- References
- 20
- FWCI
- 9.10
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.